Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 14 nov 0930 introduction biology metastasis.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Mr Adam Palmer

  18. Dr Avgi Andreou

  19. Dr Alexander Azizi

  20. Miss Ariella Stewart

  21. Mrs Abigail Redman

  22. Dr Anita Chandra

  23. Dr Aideen Daly

  24. Dr Andrea Degasperi

  25. Miss Aristi Damaskou

  26. Mr Alexander Evtushenko

  27. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  28. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  29. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

  30. Dr Alasdair Russell

    Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, we use these novel...

  31. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition NGS data analysis

  32. Dr Andrew Bannister

    I have spent the last three decades generally messing around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone modifications together with characterization of the enzymes ...

  33. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

  34. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

  35. Dr Alex Cagan

    My research seeks  to understand the somatic evolutionary processes that occur within our bodies as we age and their consequences for health.  Evolution is often considered  to be an almost imperceptibly slow process. However, the cells that...

  36. Dr Andre Neves

    As a chemical engineer, I enjoy translating basic science into novel biomedical technologies. I am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm...

  37. Dr Adelyne Chan

    Biology of Ras-induced senescence

  38. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what ...

  39. Dr Adrien Hallou

    ... from statistical and soft matter physics with wet lab biology experiments to understand the role of cellular heterogeneity in cell ...

  40. Dr Tony Jackson

    Proteomic approaches to plasma-membrane assemblies: Membrane proteins cluster together selectively as spatially-restricted, functionally integrated complexes. This can play an important role in many biological processes, including signal transduction....

  41. Dr Adrian Kelly

    Biology of MHC class I and class II antigen processing and presentation pathways.

  42. Professor Tony Green

    ... pathway has essential roles in several aspects of metazoan biology including haematopoiesis and stem cell function. Somatic mutations ...

  43. Dr Arnaud Comment

    ... by MR imaging, a recent discipline combining molecular biology and in vivo imaging, aims at differentiating tissues based upon their ...

  44. Dr Alex Samoshkin

    ... cancer research (NICHD and NCI, NIH, USA) and neuroscience biology (UNC, Chapel Hill, USA). ...

  45. Dr Ian McGough

    ... to promote further tumour growth and metastasis. Such a scenario occurs in prostate cancer, in which tumour cells ...

  46. Dr Jane Dobson

    ... area of interest is in strategies for prevention of metastasis. My principle research interest is in soft tissue sarcomas, and the ...

  47. Dr Lucy Yates

    ... heterogeneity and the evolutionary patterns underlying metastasis. My current work draws on novel genomic technologies such as in-situ ...

  48. Professor Matthew Allen

    My laboratory is interested in preclinical modelling of musculoskeletal cancer, with a particular emphasis on paediatric cancers (such as osteosarcoma, rhabdomyosarcoma and Ewings sarcoma) and adult cancers that spread to bone (such as breast, prostate,...

  49. Dr Helen Mott

    ... family, such as Cdc42 and Rac are important for invasion and metastasis. We are using a combination of structural biology and biochemical ...

  50. Dr Robert Kay

    ... and PI4P5kinase in chemotaxis. Relation of model to metastasis. Also the fundamental role of human disease proteins: ...

  51. Professor Randall Johnson

    We work on how the body responds to hypoxia, or low levels of tissue oxygen.  This is relevant to a number of diseases, including cancer, and the laboratory is interested in hypoxic response in disease as well as in normal physiology. The response to...

  52. Dr Sakari Vanharanta

    ... spread of cancer to secondary organs in a phenomenon called metastasis. Recent advances have shown that systematic experimental approaches can identify key molecular drivers of metastasis. Still, in most cases metastatic cancer remains incurable. The vast ...

Pages